US FDA devices chief should go on record over EU device failings in global dialogue
This article was originally published in RAJ Devices
The US Food and Drug Administration needs to work a great deal harder if it wants to demonstrate to those to whom it has public accountability in the US, and globally, that its medtech regulatory system works better overall for patients than the less prescriptive EU system.
You may also be interested in...
While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers the tests are not sufficiently accurate to be used in the pandemic.
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.